A study published in Clinical Breast Cancer demonstrates that Videssa Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67%. The study evaluated the performance of Videssa Breast among women under age 50.